Nektar Therapeutics | NKTR - Employees Total Number

Stock Price
85.03
Daily Change
0.87 1.03%
Monthly
11.53%
Yearly
836.04%
Q2 Forecast
84.66

Nektar Therapeutics reported 137 in Employees for its fiscal year ending in December of 2023.





Employees Change Date
Agios Pharmaceuticals 486 103 Dec/2024
ALKERMES 1.8K 300 Dec/2024
Alterity Therapeutics Limited AUD 12 1 Jun/2022
Amgen 28K 1.3K Dec/2024
Baxter International 38K 22K Dec/2024
BioCryst Pharmaceuticals 536 5 Dec/2023
Biogen 7.6K 35 Dec/2024
Bristol-Myers Squibb 34.1K 0 Dec/2024
Cara Therapeutics 55 51 Dec/2023
Cipla 30.31K 2.55K Dec/2025
Dr.Reddys Laboratories 26.94K 601 Dec/2025
Eisai 13.51K 2.44K Dec/2025
Eli Lilly 47K 4K Dec/2024
Esperion Therapeutics 240 41 Dec/2023
Exelixis 1.15K 163 Dec/2025
Gilead Sciences 17.6K 400 Dec/2024
GlaxoSmithKline 69.4K 20.7K Dec/2022
Grifols EUR 23.83K 89 Dec/2024
Halozyme Therapeutics 350 23 Dec/2024
Incyte 2.62K 93 Dec/2024
Ionis Pharmaceuticals 1.07K 142 Dec/2024
Ironwood Pharmaceuticals 267 48 Dec/2023
Karyopharm Therapeutics 325 60 Dec/2023
MacroGenics 339 18 Dec/2023
Merck 75K 3K Dec/2024
Nektar Therapeutics 137 79 Dec/2023
Neurocrine Biosciences 1.8K 400 Dec/2024
Novartis USD 101.7K 2.62K Dec/2022
Pfizer 81K 7K Dec/2024
Roche Holding 103.61K 2.69K Dec/2022
Sarepta Therapeutics 1.37K 58 Dec/2024
Takeda 47.46K 1.83K Dec/2025
Xencor 250 30 Dec/2024